The CoRE team lead by Professor John Lim, and Associate Professor Silke Vogel, complement each other’s experience to successfully guide the Centre. Professor John Lim, Executive Director of CoRE holds the concurrent appointments of Senior Advisor in the Singapore Ministry of Health, Policy Core Lead at the SingHealth Duke-NUS Global Health Institute, and inaugural Chairman of the Consortium for Clinical Research & Innovation Singapore (CRIS). He brings significant experience from his previous role as Chief Executive Officer of Singapore’s Health Sciences Authority, which he led for eight years during a period of major development and growth. With the establishment of CoRE, Associate Professor Silke Vogel was appointed Deputy Director for the Centre, in addition to her existing role as Senior Associate Dean of the Office of Graduate Studies at Duke-NUS. Her previous experiences included research and administration at the Department of Medicine at Columbia University, USA. 

Guided by its mission, CoRE envisions to create a conducive platform to meet the needs of its stakeholders, especially senior regulatory professionals in the industry and national regulatory authorities. This necessitated the formation and engagement of an Advisory Board to provide CoRE with long term strategic guidance to enhance regulatory leadership capabilities, provide a neutral platform for sharing of innovation, best practices and promote regulatory excellence in Asia. 

Established in November 2014, the Advisory Board comprises of key leaders with decades’ worth of experience in regulatory agencies, industry and academia shared between them. The Centre is honoured to have had the late Sir Alasdair Breckenridge, former Chairman of the UK Medicines and Health products Regulatory Agency, as inaugural Chairman, and is pleased to have the support of Dr Margaret Hamburg, former Foreign Secretary to the National Academy of Medicine and former Commissioner of the US Food and Drug Administration, as our current interim Chairperson.”